Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Hitomi Sumiyoshi-Okuma"'
Autor:
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Emi Noguchi, Kazuki Sudo, Kan Yonemori
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Routine measurement of tumor markers is not recommended in daily clinical practice for patients with cancer of unknown primary (CUP). We evaluated the diagnostic value of tumor markers in identifying favorable or unfavorable subse
Externí odkaz:
https://doaj.org/article/d23e0071b7ef404aa69907d7bc7e6912
Autor:
Shigemasa Takamizawa, Tatsunori Shimoi, Natsuko Satomi-Tsushita, Shu Yazaki, Toshihiro Okuya, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Kan Yonemori
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Eribulin or capecitabine monotherapy is the next cytotoxic chemotherapy option for patients with metastatic or recurrent breast cancer who have previously received an anthracycline or a taxane. However, it is unclear what factors
Externí odkaz:
https://doaj.org/article/1a3d1d1d78eb446a83f9afbf76e57338
The Selangor Consensus: strengthening clinical trials for local public health in the Western Pacific
Autor:
Kidong Park, Mengji Chen, Jinho Shin, Gui Xian Ong, Vasee Moorthy, Wei Zhang, Bin Cao, Chia Wei Phan, Chun Keat Chew, Fiona Russell, Ganzorig Dorjdagva, Hani Kim, Hitomi Sumiyoshi Okuma, Hyun-Young Park, Iris Conela Tagaro, Jing Li, Jungyeon Kim, Justin Im, Koji Wada, Koukeo Phommasone, Li Yang Hsu, Philip Rajan Devesahayam, Robyn Whittaker, Saiful Safuan Md Sani, Sheamini Sivasampu, Sushant Sahastrabuddhe, Vonthanak Saphonn, Yin Mo, Zaril Harza Zakaria
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 48, Iss , Pp 101136- (2024)
Externí odkaz:
https://doaj.org/article/b0e32b275b0f4ca0aeceb40f9e70285e
Publikováno v:
International Cancer Conference Journal. 12:216-219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1d54063d040388d3ed9a52e6433f8f6
https://doi.org/10.1007/s13691-023-00598-7
https://doi.org/10.1007/s13691-023-00598-7
Autor:
Mitsumi Terada, Kenichi Nakamura, Tomohiro Matsuda, Hitomi Sumiyoshi Okuma, Kazuki Sudo, Akhmal Yusof, Marcelo Imasa, Ekaphop Sirachainan, Pham Tuan Anh, Yasuhiro Fujiwara, Noboru Yamamoto, Pei Jye Voon, Kulkanya Chokephaibulkit, Tatsuhiro Shibata, Manami Inoue, Hiroyuki Mano, Tatsunori Shimoi, Virote Sriuranpong, Kan Yonemori, Kazuaki Shimada
Publikováno v:
Japanese Journal of Clinical Oncology.
This report summarizes the presentations and discussions in the first Asian Clinical Trials Network for Cancers (ATLAS) international symposium that was held on 24 April 2022, in Bangkok, Thailand, and hosted by the National Cancer Center Hospital (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86f157840a3ee6b24d40941e05bdbdc9
https://doi.org/10.1093/jjco/hyad033
https://doi.org/10.1093/jjco/hyad033
Autor:
Hitomi Sumiyoshi Okuma, Hiroshi Yoshida, Yoshihisa Kobayashi, Motoko Arakaki, Chiharu Mizoguchi, Lina Inagaki, Pei Jye Voon, Adam Malik Bin Ismail, Hwoei Fen Soo Hoo, Suhana Yusak, Marcelo Severino B. Imasa, Thinh Nguyen Huy, Tu Thai Anh, Shinji Kohsaka, Hiroyuki Mano, Kan Yonemori, Kenichi Nakamura, Yasushi Yatabe
Publikováno v:
Cancer Science.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1745e8964b59647c3a75969c74e657fd
https://doi.org/10.1111/cas.15790
https://doi.org/10.1111/cas.15790
Autor:
Yohei Chiba, Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Ayumi Saito, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Kan Yonemori
Publikováno v:
Translational research/biomarkers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d0ab6aadda6714d6ddf642c1edaa0b7
https://doi.org/10.1136/ijgc-2022-esgo.870
https://doi.org/10.1136/ijgc-2022-esgo.870
Autor:
Shu Yazaki, Tatsunori Shimoi, Masayuki Yoshida, Hitomi Sumiyoshi-Okuma, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Sho Shiino, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Yasuhiro Fujiwara, Kan Yonemori
Publikováno v:
Breast cancer research and treatment. 197(2)
Purpose Stromal tumor-infiltrating lymphocytes (TILs) are independent prognostic factors in systemically untreated early-stage triple-negative breast cancer (TNBC). Other immune biomarkers including CD8, CD20, programmed cell death-ligand 1 (PD-L1),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3a6b79323fb16a864c4d4b0c6021ec
https://pubmed.ncbi.nlm.nih.gov/36385236
https://pubmed.ncbi.nlm.nih.gov/36385236
Autor:
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Publikováno v:
British journal of cancer.
Background Chemotherapy and radiotherapy were postulated to induce an inflamed tumour microenvironment. We aimed to evaluate the effects of adjuvant chemotherapy/radiotherapy on tumour-infiltrating lymphocytes (TILs) and programmed death-ligand 1 (PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da76d5b0a9e9ed99814b07aaa3f79de
https://pubmed.ncbi.nlm.nih.gov/36522476
https://pubmed.ncbi.nlm.nih.gov/36522476
Publikováno v:
International Cancer Conference Journal. 12:220-220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c933d7d62eba6f41fbf35c749831c56b
https://doi.org/10.1007/s13691-023-00600-2
https://doi.org/10.1007/s13691-023-00600-2